| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |